CMS will raise Medicare Advantage plan payments by 4.08% in 2022

CMS will raise Medicare Advantage plan payments by 4.08%, the agency announced Friday.

It also signed off on its controversial proposal to complete a multiyear phase-in of a new payment methodology. The new process will adjust plan payments using diagnoses solely from encounter data—information created by healthcare providers about patients’ medical conditions and treatment. The health insurance industry has long railed against the use of encounter data to adjust their payments. They argue that the data is incomplete and often inaccurate and that using it would lead to lower payments to Advantage plans.

“This announcement is being made nearly three months earlier than usual to provide MA organizations and Part D sponsors more time to take this information into consideration as they prepare their bids for 2022,” CMS said in a fact sheet.

CMS also approved a 5.90% coding pattern adjustment for Advantage plans, which is the lowest adjustment allowed under the law. It also cemented previously approved changes to Medicare Part C and D Star Ratings.



Source link

Blog article

Healthcare’s supply chain poses the next big environmental challenge

Healthcare companies in recent years have largely focused on reducing greenhouse gas emissions as they strive to become more environmentally sustainable. While that focus has produced several innovations in conservation and alternative energy use, critics argue those actions have only scratched the surface of reducing healthcare’s climate footprint. Hospitals have remained one of the world’s […]

Read More
Blog article

Cerner to lay off 150 workers next month

New Cerner CEO Dr. David Feinberg on Thursday told employees that a set of layoffs will take place in November, a company spokesperson confirmed to Modern Healthcare. Feinberg, who took the helm as Cerner’s CEO on Oct. 1 following nearly three years leading Google Health, sent an email to employees Thursday evening after noticing a […]

Read More
Blog article

Expert panel takes up complicated COVID-19 booster questions

Influential government advisers are deciding Thursday how best to expand the nation’s COVID-19 booster campaign, including whether and when it’s OK to “mix and match” brands for the extra dose. The advisers to the Centers for Disease Control and Prevention are slated to discuss who should get extra doses of the Moderna or Johnson & […]

Read More